[Nontuberculous atypical mycobacterial infection with progressive pancytopenia in a patient with myelodysplastic syndrome]. 2001

S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
Division of Hematology and Oncology, Jikei University.

We describe a patient with myelodysplastic syndrome (MDS) who developed disseminated infection due to nontuberculous mycobacteria (NTM). A 64-year-old man was admitted because of persistent fever that had been unresponsive to antibiotics. Bone marrow aspiration specimens showed myelodysplasia (RA), but the origin of the fever was unclear. Cytopenia worsened to a level that required transfusion of red blood cells and platelets. Repeated bone marrow examination revealed hypoplasia with hemophagocytosis. Several weeks later, photochromogenic NTM was isolated from bone marrow specimens, sputum and broncho-alveolar lavage (BAL) fluid which had been obtained on admission. Antituberculosis treatment with clarithromycin markedly improved the patient's general condition and hematological abnormalities. Three months after resolution of the NTM infection, the peripheral blood monocyte count increased, the fever recurred, and the patient suddenly died of myocardial infarction. Disseminated infection with NTM has gained attention as a frequent complication of AIDS, and NTM can also be one of the pathogens causing disseminated infection in patients with MDS. In the present case, infection with mycobacteria that normally would have been digested by macrophages and would not have caused disseminated infection in a healthy individual, was probably related to the clinical features including high fever, severe pancytopenia and hemophagocytosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009165 Mycobacterium Infections, Nontuberculous Infections with nontuberculous mycobacteria (atypical mycobacteria): M. kansasii, M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae), M. chelonae, M. leprae. Mycobacterium Infections, Atypical,Atypical Mycobacterial Infection, Disseminated,Atypical Mycobacterial Infection, Familial Disseminated,Atypical Mycobacteriosis, Familial,Atypical Mycobacteriosis, Familial Disseminated,Atypical Mycobacterium Infections,Infections, Atypical Mycobacterium,Mycobacterium abscessus Infection,Atypical Mycobacterium Infection,Familial Atypical Mycobacterioses,Familial Atypical Mycobacteriosis,Infection, Mycobacterium abscessus,Infections, Mycobacterium abscessus,Mycobacterioses, Familial Atypical,Mycobacteriosis, Familial Atypical,Mycobacterium Infection, Atypical,Mycobacterium Infection, Nontuberculous,Mycobacterium abscessus Infections,Nontuberculous Mycobacterium Infection,Nontuberculous Mycobacterium Infections
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D010198 Pancytopenia Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets. Pancytopenias
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015616 Histiocytosis, Non-Langerhans-Cell Group of disorders which feature accumulations of active HISTIOCYTES and LYMPHOCYTES, but where the histiocytes are not LANGERHANS CELLS. The group includes HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SINUS HISTIOCYTOSIS; xanthogranuloma; reticulohistiocytoma; JUVENILE XANTHOGRANULOMA; xanthoma disseminatum; as well as the lipid storage diseases (SEA-BLUE HISTIOCYTE SYNDROME; and NIEMANN-PICK DISEASES). Reticulohistiocytoma,Xanthoma Disseminatum,Disseminatum, Xanthoma,Histiocytosis, Non Langerhans Cell,Non-Langerhans-Cell Histiocytosis,Reticulohistiocytomas
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
May 1968, Archives of internal medicine,
S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
April 2010, Leukemia research,
S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
January 2021, European journal of radiology open,
S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
December 2022, JAAPA : official journal of the American Academy of Physician Assistants,
S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
February 2019, BMC pulmonary medicine,
S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
November 2001, The Mount Sinai journal of medicine, New York,
S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
September 2019, Clinical lymphoma, myeloma & leukemia,
S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
June 1985, American journal of diseases of children (1960),
S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
December 2017, Acta medica Okayama,
S Nakada, and T Sekikawa, and S Takahara, and Y Yamazaki, and J Yamada, and H Yamada, and S Iwase, and M Kobayashi
September 2023, BMJ case reports,
Copied contents to your clipboard!